Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value
$1.51B
Total Bought
$596.44M
Total Sold
$173.21M
Net Transaction
+$423.23M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
HEARTFLOW INC(HTFL)012,448,158+12,448,1580419,00527.81%+419,005
CIDARA THERAPEUTICS INC2,500,6803,020,990+520,310121,808289,29019.20%+167,482
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
10,719,11010,719,1100194,123304,85120.23%+110,728
OLEMA PHARMACEUTICALS INC(OLMA)6,843,9546,843,954029,15567,0024.45%+37,847
SAVARA INC(SVRA)17,600,62117,600,621040,12962,8344.17%+22,705
PHARVARIS N V
COM
3,303,3813,181,275-122,10658,14079,3735.27%+21,233
UPSTREAM BIO INC(UPB)2,439,5382,439,538026,78645,8883.05%+19,102
SOLID BIOSCIENCES INC7,911,6697,911,669038,53048,8153.24%+10,285
KYVERNA THERAPEUTICS INC(KYTX)3,368,3703,368,370010,34120,2101.34%+9,869
TANGO THERAPEUTICS INC(TNGX)2,712,0082,712,008013,88522,7811.51%+8,895
CABALETTA BIO INC(CABA)9,677,1259,677,125014,70922,6441.50%+7,935
X4 PHARMACEUTICALS INC(XFOR)563,8592,436,588+1,872,7291,0718,3330.55%+7,262
DIANTHUS THERAPEUTICS INC(DNTH)2,482,2501,315,892-1,166,35846,24451,7803.44%+5,536
ANNEXON INC(ANNX)5,249,0695,249,069012,59816,0101.06%+3,412
MERSANA THERAPEUTICS INC0346,545+346,54502,6890.18%+2,689
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
100,000100,00008001,7110.11%+911
C4 THERAPEUTICS INC(CCCC)1,111,9101,111,91001,5902,4680.16%+878
XILIO THERAPEUTICS INC(XLO)4,566,8174,566,81703,1053,8480.26%+743
RAPID MICRO BIOSYSTEMS INC(RPID)8,434,5608,434,560029,09928,1711.87%-928
CENTURY THERAPEUTICS INC(IPSC)5,410,3613,538,609-1,871,7523,0231,7620.12%-1,261
INVIVYD INC(IVVD)1,799,5950-1,799,5951,2870—-1,287
ATEA PHARMACEUTICALS INC(AVIR)2,485,6382,485,63808,9487,2080.48%-1,740
MERSANA THERAPEUTICS INC8,663,6730-8,663,6732,5640—-2,564
DISC MEDICINE INC(IRON)583,5000-583,50030,9020—-30,902
NUVALENT INC1,447,2670-1,447,267110,4260—-110,426
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q3 2025 | TickerTrail